| Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis P Teira, M Battiwalla, M Ramanathan, AJ Barrett, KW Ahn, M Chen, ... Blood, The Journal of the American Society of Hematology 127 (20), 2427-2438, 2016 | 500 | 2016 |
| Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study T Güngör, P Teira, M Slatter, G Stussi, P Stepensky, D Moshous, ... The Lancet 383 (9915), 436-448, 2014 | 346 | 2014 |
| Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients J Kurtzberg, S Prockop, P Teira, H Bittencourt, V Lewis, KW Chan, B Horn, ... Biology of blood and marrow transplantation 20 (2), 229-235, 2014 | 280 | 2014 |
| SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery E Haddad, BR Logan, LM Griffith, RH Buckley, RE Parrott, SE Prockop, ... Blood, The Journal of the American Society of Hematology 132 (17), 1737-1749, 2018 | 147 | 2018 |
| CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia S Vairy, JL Garcia, P Teira, H Bittencourt Drug design, development and therapy, 3885-3898, 2018 | 107 | 2018 |
| Autophagy is associated with chemoresistance in neuroblastoma A Belounis, C Nyalendo, R Le Gall, TV Imbriglio, M Mahma, P Teira, ... BMC cancer 16, 1-14, 2016 | 78 | 2016 |
| The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit P Demaret, G Pettersen, P Hubert, P Teira, G Emeriaud Annals of intensive care 2, 1-11, 2012 | 68 | 2012 |
| Expression of disialoganglioside (GD2) in neuroblastic tumors: a prognostic value for patients treated with anti-GD2 immunotherapy T Terzic, M Cordeau, S Herblot, P Teira, S Cournoyer, M Beaunoyer, ... Pediatric and Developmental Pathology 21 (4), 355-362, 2018 | 65 | 2018 |
| Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia R Micol, S Kayal, N Mahlaoui, J Beauté, P Brosselin, Y Dudoit, G Obenga, ... Journal of allergy and clinical immunology 129 (3), 770-777, 2012 | 64 | 2012 |
| Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation … T Güngör, P Teira, M Slatter, G Stussi, P Stepensky, D Moshous, ... Lancet 383 (9915), 436-448, 2014 | 51 | 2014 |
| Study 275: updated expanded access program for remestemcel-L in steroid-refractory acute graft-versus-host disease in children J Kurtzberg, S Prockop, S Chaudhury, B Horn, E Nemecek, V Prasad, ... Biology of Blood and Marrow Transplantation 26 (5), 855-864, 2020 | 50 | 2020 |
| Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT AL Herr, N Kabbara, CMS Bonfim, P Teira, F Locatelli, K Tiedemann, ... Blood, The Journal of the American Society of Hematology 116 (11), 1849-1856, 2010 | 49 | 2010 |
| Molecular profiling of hard-to-treat childhood and adolescent cancers F Khater, S Vairy, S Langlois, S Dumoucel, T Sontag, P St-Onge, ... JAMA network open 2 (4), e192906-e192906, 2019 | 48 | 2019 |
| Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia N Bejanyan, S Kim, KM Hebert, N Kekre, H Abdel-Azim, I Ahmed, M Aljurf, ... Blood advances 3 (20), 3123-3131, 2019 | 47 | 2019 |
| Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation ABM Madureira, M Eapen, F Locatelli, P Teira, MJ Zhang, SM Davies, ... Leukemia 25 (3), 449-454, 2011 | 46 | 2011 |
| Chronic granulomatous disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT RA Marsh, JW Leiding, BR Logan, LM Griffith, DE Arnold, E Haddad, ... Journal of clinical immunology 39, 653-667, 2019 | 44 | 2019 |
| Impact of early CMV reactivation in cord blood stem cell recipients in the current era M Ramanathan, P Teira, M Battiwalla, J Barrett, KW Ahn, M Chen, J Green, ... Bone marrow transplantation 51 (8), 1113-1120, 2016 | 44 | 2016 |
| Outcomes of measurable residual disease in pediatric acute myeloid leukemia before and after hematopoietic stem cell transplant: validation of difference from normal flow … DA Jacobsohn, MR Loken, M Fei, A Adams, LE Brodersen, BR Logan, ... Biology of Blood and Marrow Transplantation 24 (10), 2040-2046, 2018 | 37 | 2018 |
| Improvement of the outcome of relapsed or refractory acute lymphoblastic leukemia in children using a risk-based treatment strategy F Ceppi, M Duval, JM Leclerc, C Laverdiere, YL Delva, S Cellot, P Teira, ... PLoS One 11 (9), e0160310, 2016 | 32 | 2016 |
| Genotype analysis of tumor‐initiating cells expressing CD133 in neuroblastoma S Cournoyer, C Nyalendo, A Addioui, A Belounis, M Beaunoyer, ... Genes, Chromosomes and Cancer 51 (8), 792-804, 2012 | 29 | 2012 |
